Home > Insider Trading > Filing (0001209191-15-070584)

Filing Details

Accession Number:: 0001209191-15-070584
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-09-14 18:26:17
Reporting Period:: 2015-09-10

Filing Date:: 2015-09-14
Accepted Time:: 2015-09-14 18:26:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1469443	Arcadia Biosciences Inc.	RKDA	Agricultural Chemicals (2870)	810571538

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640702	Don Emlay	C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618	Vp Regulatory And Compliance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-09-10	1,588	$0.44	12,838	No	4	M	Direct
Common Stock	Disposition	2015-09-10	548	$5.27	12,290	No	4	S	Direct
Common Stock	Acquisiton	2015-09-11	6,397	$0.44	18,687	No	4	M	Direct
Common Stock	Disposition	2015-09-11	2,284	$4.92	16,403	No	4	S	Direct
Common Stock	Acquisiton	2015-09-14	2,015	$0.44	18,418	No	4	M	Direct
Common Stock	Disposition	2015-09-14	689	$4.81	17,729	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-09-10	1,588	$0.00	1,588	$0.44
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-09-11	6,397	$0.00	6,397	$0.44
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-09-14	2,015	$0.00	2,015	$0.44

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,412	2015-12-31	No	4	M	Direct
2,015	2015-12-31	No	4	M	Direct
0	2015-12-31	No	4	M	Direct

Footnotes

The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015. Pursuant to the Plan and in compliance with the Issuer's IPO Lock-up Agreements with Credit Suisse Securities (USA) ("CSSU"), the Reporting Person paid the exercise price and CSSU sold shares only to satisfy the tax liability and costs. The balance of the shares will be held until the expiration of the IPO Lock-up Agreements.
This transaction was executed in multiple trades at prices ranging from $5.10 to $5.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $4.79 to $5.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $4.780 to $4.850. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option is fully exercisable as of the date hereof.